The present invention provides a stationary phase for solid-phase microextraction (SPME) devices based on nickel and titanium alloy nuclei and a metal-organic framework (MOF) exterior, which may be used for chromatographic analysis in environmental, food, etc. applications. The method of preparation of the stationary phases consists of a number of steps which provide a covalent adhesion of the MOF to the nickel/titanium alloy. In these stationary phases, the metal-organic framework is the only component that comes into contact with the sample to be analysed. The interior of the stationary phase is executed in nitinol and endows the system with thermal and mechanical stability, this being the first time that it is used to support a metal-organic framework, and presenting extractive advantages in comparison with commercial SPME stationary phases.

A protective fabric which includes at least one structural layer and a ceramic composite material layer fixed to the at least one structural layer, is provided. The structural layer can include a non-woven material made from or containing synthetic fibers. The ceramic composite material layer is formed of ceramic composite material powder which includes a ceramic carrier, and iron-silver crystals containing zero-valent iron and zero-valent silver supported on the ceramic carrier. The protective fabric is effective for removing VOCs, suppressing bacterial growth, and filtering or inactivating virus, such as SARS-CoV-2 virus. Protective products or articles incorporating the protective fabric are also provided.

A filter apparatus for removing small molecule chemotherapy agents from blood is provided. The filter apparatus comprises a housing with an extraction media comprised of polymer coated carbon cores. Also provided are methods of treating a subject with cancer of an organ or region comprising administering a chemotherapeutic agent to the organ or region, collecting blood laded with chemotherapeutic agent from the isolated organ, filtering the blood laden with chemotherapeutic agent to reduce the chemotherapeutic agent in the blood and returning the blood to the subject.

The invention discloses a separation matrix comprised of porous spherical particles to which antibody-binding protein ligands have been covalently immobilized, wherein the density of said ligands is in the range of 10.5-15 mg/ml and the volume-weighted median diameter of said particles is in the range of 30-55 μm.

The invention discloses a separation matrix for purification of biological particles, comprising a plurality of particles having a porous core entity and a porous shell entity covering the core entity, wherein the core entity comprises at least 50 micromole/ml primary amines present on covalently attached ligands displaying at least two primary amines per ligand and the shell entity comprises less than 20 micromole/ml primary amines The invention further discloses a method of purifying biological particles and a method of manufacturing a separation matrix.

A water absorption treatment material includes a core portion and a coating portion. The core portion is approximately circular column-shaped and has a side surface, a first bottom surface, and a second bottom surface. The coating portion is provided so as to cover the core portion. A region of 80% or more of the side surface of the core portion is covered by the coating portion. A region of 80% or more of the first bottom surface of the core portion is exposed without being covered by the coating portion.

An object of the present invention is to provide a packing material suitable for use as a packing material for size exclusion chromatography for fractionation that requires large-scale treatment, the packing material being capable of being produced by a simple process and reducing column pressure drop even when the particle diameter is small, and is to provide a method for producing the packing material. In the present invention, a packing material for size exclusion chromatography is obtained by a production process including polymerizing glycerol 1,3-dimethacrylate and glycidyl methacrylate in the presence of a polymerization initiator, hydrophilizing the resulting porous particles made of a copolymer using a sugar alcohol, and then opening the rings of remaining glycidyl groups using a mineral acid.

A protective fabric which includes at least one structural layer and a ceramic composite material layer fixed to the at least one structural layer, is provided. The structural layer can include a non-woven material made from or containing synthetic fibers. The ceramic composite material layer is formed of ceramic composite material powder which includes a ceramic carrier, and iron-silver crystals containing zero-valent iron and zero-valent silver supported on the ceramic carrier. The protective fabric is effective for removing VOCs, suppressing bacterial growth, and filtering or inactivating virus, such as SARS-CoV-2 virus. Protective products or articles incorporating the protective fabric are also provided.

Provided is a method for preparing a superabsorbent polymer. More particularly, provided is a method for preparing a superabsorbent polymer having a reduced amount of coarse particles with a particle size of more than 850 μm and an improved water content, and exhibiting excellent absorption performances without deviation.

The present invention relates to a method and apparatus for providing and/or receiving audible sound. In particular, the invention relates to apparatus, such as a micro speaker, which includes an active region which comprises an adsorbent element in the form of a self-supporting monolith-like element with a porous reticulated structure. The adsorbent element includes adsorbent material which comprises microporous organic polymer (MOP) material. The apparatus of the present invention is suitable for use in an electronic device, for example a mobile or portable electronic device, to provide improved audible sound.